Back to Search
ROSS DONEHOWER, M.D.
M.D.
Medical Oncology Physician
NPI: 1780631713Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
D23675(MD)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Class of 1974
Research & Publications (20)
Evaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay.
PMID 19029951·Oncogene·2009
7-preclinical
Adjuvant chemoradiation versus surgery alone for adenocarcinoma of the ampulla of Vater.
PMID 19541379·Radiother Oncol·2009
4-observational
Analysis of circulating tumor DNA to confirm somatic KRAS mutations.
PMID 19641175·J Natl Cancer Inst·2009
8-other
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.
PMID 18640931·J Clin Oncol·2008
8-other
A phase I study of EKB-569 in combination with capecitabine in patients with advanced colorectal cancer.
PMID 18765554·Clin Cancer Res·2008
3-trial
Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumors.
PMID 18757332·J Clin Oncol·2008
3-trial
Phase I study of troxacitabine administered by continuous infusion in subjects with advanced solid malignancies.
PMID 18245131·Ann Oncol·2008
3-trial
Phase I study of ON 01910.Na, a novel modulator of the Polo-like kinase 1 pathway, in adult patients with solid tumors.
PMID 18955447·J Clin Oncol·2008
3-trial
Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors.
PMID 18379785·Cancer Chemother Pharmacol·2008
3-trial
Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors.
PMID 17429623·Cancer Chemother Pharmacol·2008
3-trial
Interventions for preventing neuropathy caused by cisplatin and related compounds.
PMID 17253547·Cochrane Database Syst Rev·2007
1-meta
Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct.
PMID 17276614·Int J Radiat Oncol Biol Phys·2007
8-other
Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum.
PMID 17372054·Arch Surg·2007
8-other
Phase I study of continuous weekly dosing of dimethylamino benzoylphenylurea (BPU) in patients with solid tumours.
PMID 17084620·Eur J Cancer·2007
3-trial
Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate ON 01910.Na, a mitotic progression modulator, in human plasma.
PMID 17588831·J Chromatogr B Analyt Technol Biomed Life Sci·2007
4-observational
Phase II study of erlotinib in patients with advanced biliary cancer.
PMID 16809731·J Clin Oncol·2006
3-trial
Phase I trial of bortezomib in combination with docetaxel in patients with advanced solid tumors.
PMID 16489083·Clin Cancer Res·2006
3-trial
A Phase I study of the oral antimetabolite, CS-682, administered once daily 5 days per week in patients with refractory solid tumor malignancies.
PMID 16788861·Invest New Drugs·2006
3-trial
A phase I and pharmacokinetic study of short infusions of UCN-01 in patients with refractory solid tumors.
PMID 15701854·Clin Cancer Res·2005
3-trial
Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer.
PMID 16170173·J Clin Oncol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10755 FALLS RD
LUTHERVILLE, MD 21093 - Phone
- (410) 583-2970
Quick Facts
- NPI
- 1780631713
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 52
- Publications
- 20
Are you this provider?
Claim Your Profile